Sullivan
Microsoft has discontinued support for Internet Explorer. To access the Sullivan website, please install a modern browser like Microsoft Edge or Google Chrome.

Commercial & Technology Transactions

  • Represented a world leader in quantum computing equipment in sales to major technology companies, government laboratories and other institutions.
  • Represented a qualitative due diligence firm in developing library and data subscription products and negotiating related master licensing and commercial agreements.
  • Represented a Finnish sauna manufacturer in preparing U.S. online terms and conditions and privacy policy.
  • Represented a startup consumer packaged goods information supply‑chain provider in commercial and IP matters supporting platform development, technical leadership onboarding, and branding.
  • Represented a technology design house in commercial agreements with major telecom device manufacturers, chip producers and component suppliers.
  • Represented a payroll services provider in the negotiation of core technology vendor and platform agreements supporting its service offering.

Brand, Media, Advertising & Consumer Transactions

  • Represented a world-famous kitchen and home goods brand in the negotiation and drafting of exclusive product‑category trademark license agreements.
  • Represented a product design services agency in its negotiation of a creative services agreement with a multinational consumer products company.
  • Represented a European golf clubs brand in its negotiation of a multi-million-dollar influencer marketing deal focused on growth in the U.S. market.
  • Represented a digital marketing agency in the negotiation of services agreements with top U.S. financial institutions, credit card companies and consumer products companies.
  • Represented an e‑commerce advertising and intelligence provider in negotiating and documenting an enterprise software‑as‑a‑service agreement with a multinational electronics company.
  • Represented a blockchain‑based advertising technology firm in negotiating a software‑as‑a‑service and professional services agreement with a media‑buying and advertising technology company.

Life Sciences, Digital Health & Institutional Licensing

  • Represented a clinical trial software provider in its spin‑out from a major academic health system, including negotiating a license to the parent institution’s proprietary technology.
  • Represented a pharmaceutical company in the negotiation of patent royalty agreements relating to certain pipeline products in connection with its merger with another biopharmaceutical company.
  • Represented a Finnish clinical‑stage drug‑delivery and development company in negotiating an exclusive license agreement with a global pharmaceutical company, with potential milestone payments of up to $200 million plus royalties on net sales.
  • Represented a European biotechnology company in negotiating and documenting a know‑how license agreement with a major U.S. medical research institution to advance tissue‑regeneration solutions.
  • Represented a Nordic medical device developer and supplier in its negotiation of a U.S. product distribution agreement with a major global medical technology company.
  • Represented a digital health solutions provider in negotiating a master agreement for delivery of a digital health platform, devices, and professional services to members of a national managed‑care organization.

Strategic, IP‑Driven & Corporate Transactions

  • Represented a NASDAQ-listed data experience, valuation, and monetization company in negotiating and documenting a software development agreement and cross‑license and marketing agreement in connection with a $50 million share exchange.
  • Represented a U.S. biotechnology startup in the sale of certain gene‑therapy programs and related intellectual property for the treatment or prevention of hearing loss, deafness, and balance disorders.
  • Represented a publicly traded biopharmaceutical company in structuring multi‑party royalty monetization arrangements tied to a transformative merger and financing, including the sale of global product revenue streams across multiple therapeutic platforms.

Matters

Commercial & Technology Transactions

  • Represented a world leader in quantum computing equipment in sales to major technology companies, government laboratories and other institutions.
  • Represented a qualitative due diligence firm in developing library and data subscription products and negotiating related master licensing and commercial agreements.
  • Represented a Finnish sauna manufacturer in preparing U.S. online terms and conditions and privacy policy.
  • Represented a startup consumer packaged goods information supply‑chain provider in commercial and IP matters supporting platform development, technical leadership onboarding, and branding.
  • Represented a technology design house in commercial agreements with major telecom device manufacturers, chip producers and component suppliers.
  • Represented a payroll services provider in the negotiation of core technology vendor and platform agreements supporting its service offering.

Brand, Media, Advertising & Consumer Transactions

  • Represented a world-famous kitchen and home goods brand in the negotiation and drafting of exclusive product‑category trademark license agreements.
  • Represented a product design services agency in its negotiation of a creative services agreement with a multinational consumer products company.
  • Represented a European golf clubs brand in its negotiation of a multi-million-dollar influencer marketing deal focused on growth in the U.S. market.
  • Represented a digital marketing agency in the negotiation of services agreements with top U.S. financial institutions, credit card companies and consumer products companies.
  • Represented an e‑commerce advertising and intelligence provider in negotiating and documenting an enterprise software‑as‑a‑service agreement with a multinational electronics company.
  • Represented a blockchain‑based advertising technology firm in negotiating a software‑as‑a‑service and professional services agreement with a media‑buying and advertising technology company.

Life Sciences, Digital Health & Institutional Licensing

  • Represented a clinical trial software provider in its spin‑out from a major academic health system, including negotiating a license to the parent institution’s proprietary technology.
  • Represented a pharmaceutical company in the negotiation of patent royalty agreements relating to certain pipeline products in connection with its merger with another biopharmaceutical company.
  • Represented a Finnish clinical‑stage drug‑delivery and development company in negotiating an exclusive license agreement with a global pharmaceutical company, with potential milestone payments of up to $200 million plus royalties on net sales.
  • Represented a European biotechnology company in negotiating and documenting a know‑how license agreement with a major U.S. medical research institution to advance tissue‑regeneration solutions.
  • Represented a Nordic medical device developer and supplier in its negotiation of a U.S. product distribution agreement with a major global medical technology company.
  • Represented a digital health solutions provider in negotiating a master agreement for delivery of a digital health platform, devices, and professional services to members of a national managed‑care organization.

Strategic, IP‑Driven & Corporate Transactions

  • Represented a NASDAQ-listed data experience, valuation, and monetization company in negotiating and documenting a software development agreement and cross‑license and marketing agreement in connection with a $50 million share exchange.
  • Represented a U.S. biotechnology startup in the sale of certain gene‑therapy programs and related intellectual property for the treatment or prevention of hearing loss, deafness, and balance disorders.
  • Represented a publicly traded biopharmaceutical company in structuring multi‑party royalty monetization arrangements tied to a transformative merger and financing, including the sale of global product revenue streams across multiple therapeutic platforms.